Advertisement
Advertisement

CLGN

CLGN logo

CollPlant Biotechnologies Ltd Ordinary Shares

0.34
USD
Sponsored
-0.02
-4.43%
Jun 24, 15:38 UTC -4
Closed
exchange

After-Market

0.35

+0.01
+4.34%

CLGN Earnings Reports

Positive Surprise Ratio

CLGN beat 3 of 26 last estimates.

12%

Next Report

Date of Next Report
Aug 18, 2026
Estimate for Q2 26 (Revenue/ EPS)
$5.24M
/
$0.05
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
+2828.94%
/
-117.86%

CollPlant Biotechnologies Ltd Ordinary Shares earnings per share and revenue

On May 29, 2026, CLGN reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.19 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.12 million, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.05 USD, with revenue projected to reach 5.24 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, CollPlant Biotechnologies Ltd Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 18, 2026.
Based on -- analysts, CollPlant Biotechnologies Ltd Ordinary Shares is expected to report EPS of $0.05 and revenue of $5.24M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement